Author

Svend Poulsen

Novo Nordisk (Denmark)ORCID 0000-0002-5010-6992Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1

Frequent Co-Authors

Peder Lisby Nørby· 2 shared Aaron NovikoffiD· 1 shared Andreas HaldiD· 1 shared BARENT N. DUBOIS· 1 shared Birgitte Martine ViuffiD· 1 shared Brian FinaniD· 1 shared Chris J. WestoniD· 1 shared Daniel J. DruckeriD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersZoology

Peder Lisby Nørby

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ZoologyMolecular MetabolismPeer-reviewedFeb 5, 2026

Ectopic, hepatic GLP-1R agonism enhances the weight loss efficacy of GLP-1 analogues.

Jonathan D. Douros, Megan E. Capozzi, Aaron Novikoff…·Patrick J. Knerr

The paper shows that combining GLP-1R agonists with ectopic hepatic GLP-1R expression enhances weight loss in mice by increasing energy expenditure and reducing food intake.

1 citation

mouseexperimental assay

𝕏 PostBluesky

PathologyeLifePeer-reviewedJul 8, 2024

Evaluation of Gremlin-1 as a therapeutic target in metabolic dysfunction-associated steatohepatitis

Paul Horn, Jenny Norlin, Kasper Almholt…·Philip Noel Newsome

This study evaluates Gremlin-1 as a therapeutic target in MASH fibrosis, finding it upregulated but not amenable to targeting due to its restricted expression and lack of effect on fibrogenesis.

7 citations

rathuman

𝕏 PostBluesky